# Neurogene (NGNE) — Earnings

NGNE · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ngne/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$1.05 |
| EPS estimate | −$1.16 |
| EPS surprise | +9.47% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 11, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1404644/000140464425000081/ngne-20250630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 11, 2025 | −$1.16 | −$1.05 | 9.47% | — | — |
| Q1 2025 | May 9, 2025 | −$1.05 | −$1.08 | -2.86% | — | — |
| Q4 2024 | Mar 24, 2025 | −$1.13 | −$1.00 | 11.42% | — | — |
| Q3 2024 | Nov 18, 2024 | −$1.22 | −$1.19 | 2.59% | — | — |
| Q2 2024 | Aug 9, 2024 | −$1.05 | −$1.09 | -3.85% | — | $925,000.00 |
| Q1 2024 | May 10, 2024 | −$1.03 | −$1.00 | 3.29% | — | — |
| Q4 2023 | Mar 18, 2024 | −$1.17 | $2.93 | 349.72% | — | — |
| Q3 2023 | Nov 14, 2023 | −$0.60 | −$2.47 | -311.67% | — | — |
| Q1 2023 | May 8, 2023 | −$4.40 | −$5.20 | -18.18% | — | — |
| Q3 2022 | Nov 14, 2022 | −$6.09 | −$4.80 | 21.13% | — | — |
| Q2 2022 | Aug 9, 2022 | −$6.00 | −$5.60 | 6.67% | — | — |
| Q1 2022 | May 9, 2022 | −$5.96 | −$5.60 | 6.04% | — | — |
| Q4 2021 | Mar 1, 2022 | −$5.91 | −$5.60 | 5.31% | — | — |
| Q3 2021 | Nov 4, 2021 | −$5.57 | −$5.60 | -0.60% | — | — |
| Q2 2021 | Aug 5, 2021 | −$5.24 | −$5.40 | -3.05% | — | — |
| Q1 2021 | May 12, 2021 | −$4.56 | −$5.40 | -18.42% | — | — |
| Q4 2020 | Mar 25, 2021 | −$4.89 | −$4.40 | 9.94% | — | — |
| Q3 2020 | Nov 9, 2020 | −$4.40 | −$0.80 | 81.82% | — | — |
| Q2 2020 | Aug 12, 2020 | −$4.20 | −$4.00 | 4.76% | — | — |
| Q1 2020 | May 6, 2020 | −$4.60 | −$3.60 | 21.74% | — | — |

## Frequently Asked Questions

### When did Neurogene (NGNE) last report earnings?

Neurogene last reported on Aug 11, 2025, covering fiscal Q2 2025.

### Did NGNE beat earnings estimates?

Yes. Neurogene reported EPS of −$1.05 for Q2 2025 against a −$1.16 estimate — a 9.47% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).